Surgical adjuvant hormonal therapy with high dose medroxyprogesterone acetate (MAP) in breast cancer. Results 36 months after mastectomy

Panminerva Med. 1982 Jul-Sep;24(3):187-94.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Mastectomy
  • Medroxyprogesterone / administration & dosage*
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Postoperative Care

Substances

  • Medroxyprogesterone